Shares in Dr. Martens were down 11 per cent on Thursday afternoon after its largest shareholder sold a stake in the footwear giant.
Permira, via its Luxembourg-based IngreLux fund, sold its shares at a price of 395p for total proceeds of around £257m.
The private equity group acquired control of the retailer in 2013 for £300m and floated it back on the market last January via an initial public offering (IPO), leading to a market valuation of £3.7bn.
Analysts said Permira sold the shares at an opportune time as the retailer’s annual revenue growth is anticipated to slow over the next two years to 14 per cent, according to Refinitiv.
Read more/Source: City A.M.
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.